Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) shot up 9.1% on Friday . The company traded as high as C$0.12 and last traded at C$0.12. 835,000 shares traded hands during trading, an increase of 756% from the average session volume of 97,601 shares. The stock had previously closed at C$0.11.
Voyageur Pharmaceuticals Stock Performance
The company has a 50 day simple moving average of C$0.10 and a 200-day simple moving average of C$0.13. The company has a debt-to-equity ratio of 6.05, a current ratio of 0.18 and a quick ratio of 0.84. The stock has a market cap of C$23.33 million, a P/E ratio of -13.00 and a beta of 0.78.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.
Featured Articles
- Five stocks we like better than Voyageur Pharmaceuticals
- Rocket Lab’s NASA Win Tests Key Support After Sharp Pullback
- AST SpaceMobile Just Nailed a Major Launch—So Why Is the Stock Crashing?
- Palantir’s Valuation Problem Just Met 2 New Growth Catalysts
- Xcel Energy Stock Offers Stability as Electricity Demand Builds
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
